Vikram Kesavabhotla
Stock Analyst at Baird
(3.57)
# 893
Out of 4,732 analysts
43
Total ratings
54.84%
Success rate
6.06%
Average return
Main Sectors:
Stocks Rated by Vikram Kesavabhotla
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GDDY GoDaddy | Maintains: Outperform | $200 → $225 | $200.91 | +11.99% | 8 | Nov 19, 2024 | |
| ROKU Roku, Inc. | Upgrades: Outperform | $70 → $90 | $75.89 | +18.59% | 3 | Nov 18, 2024 | |
| TTD The Trade Desk | Maintains: Outperform | $130 → $140 | $124.42 | +12.52% | 3 | Nov 8, 2024 | |
| DOCS Doximity | Maintains: Outperform | $41 → $45 | $53.72 | -16.23% | 3 | Sep 17, 2024 | |
| DH Definitive Healthcare | Maintains: Neutral | $6 → $5 | $3.94 | +26.90% | 4 | Aug 7, 2024 | |
| DV DoubleVerify Holdings | Maintains: Outperform | $42 → $34 | $19.47 | +74.63% | 3 | May 8, 2024 | |
| SPOT Spotify Technology | Maintains: Outperform | $185 → $225 | $485.53 | -53.66% | 2 | Dec 8, 2023 | |
| IAS Integral Ad Science Holding | Initiates: Outperform | $19 | $10.04 | +89.24% | 1 | Aug 18, 2023 | |
| NFLX Netflix | Upgrades: Outperform | $340 → $500 | $858.10 | -41.73% | 1 | Jul 24, 2023 | |
| HIMS Hims & Hers Health | Initiates: Neutral | $10 | $27.85 | -64.09% | 1 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $50 | $32.74 | +52.72% | 1 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $23 | $7.70 | +198.70% | 1 | Apr 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $7 → $6 | $4.57 | +31.29% | 4 | Jun 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $6 → $5 | $3.57 | +40.06% | 2 | May 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $3 | $3.02 | -0.66% | 3 | Nov 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $58 → $54 | $6.89 | +683.74% | 2 | Sep 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $30 | $11.66 | +157.29% | 1 | Jul 23, 2021 |
GoDaddy
Nov 19, 2024
Maintains: Outperform
Price Target: $200 → $225
Current: $200.91
Upside: +11.99%
Roku, Inc.
Nov 18, 2024
Upgrades: Outperform
Price Target: $70 → $90
Current: $75.89
Upside: +18.59%
The Trade Desk
Nov 8, 2024
Maintains: Outperform
Price Target: $130 → $140
Current: $124.42
Upside: +12.52%
Doximity
Sep 17, 2024
Maintains: Outperform
Price Target: $41 → $45
Current: $53.72
Upside: -16.23%
Definitive Healthcare
Aug 7, 2024
Maintains: Neutral
Price Target: $6 → $5
Current: $3.94
Upside: +26.90%
DoubleVerify Holdings
May 8, 2024
Maintains: Outperform
Price Target: $42 → $34
Current: $19.47
Upside: +74.63%
Spotify Technology
Dec 8, 2023
Maintains: Outperform
Price Target: $185 → $225
Current: $485.53
Upside: -53.66%
Integral Ad Science Holding
Aug 18, 2023
Initiates: Outperform
Price Target: $19
Current: $10.04
Upside: +89.24%
Netflix
Jul 24, 2023
Upgrades: Outperform
Price Target: $340 → $500
Current: $858.10
Upside: -41.73%
Hims & Hers Health
Apr 11, 2023
Initiates: Neutral
Price Target: $10
Current: $27.85
Upside: -64.09%
Apr 11, 2023
Initiates: Outperform
Price Target: $50
Current: $32.74
Upside: +52.72%
Apr 11, 2023
Initiates: Outperform
Price Target: $23
Current: $7.70
Upside: +198.70%
Jun 22, 2022
Maintains: Neutral
Price Target: $7 → $6
Current: $4.57
Upside: +31.29%
May 16, 2022
Downgrades: Neutral
Price Target: $6 → $5
Current: $3.57
Upside: +40.06%
Nov 16, 2021
Downgrades: Neutral
Price Target: $10 → $3
Current: $3.02
Upside: -0.66%
Sep 17, 2021
Upgrades: Outperform
Price Target: $58 → $54
Current: $6.89
Upside: +683.74%
Jul 23, 2021
Initiates: Outperform
Price Target: $30
Current: $11.66
Upside: +157.29%